118 related articles for article (PubMed ID: 9406667)
1. Prostanoid action on the human pulmonary vascular system.
Jones RL; Qian Y; Wong HN; Chan H; Yim AP
Clin Exp Pharmacol Physiol; 1997 Dec; 24(12):969-72. PubMed ID: 9406667
[TBL] [Abstract][Full Text] [Related]
2. Potent contractile actions of prostanoid EP3-receptor agonists on human isolated pulmonary artery.
Qian YM; Jones RL; Chan KM; Stock AI; Ho JK
Br J Pharmacol; 1994 Oct; 113(2):369-74. PubMed ID: 7834185
[TBL] [Abstract][Full Text] [Related]
3. Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.
Walch L; de Montpreville V; Brink C; Norel X
Br J Pharmacol; 2001 Dec; 134(8):1671-8. PubMed ID: 11739243
[TBL] [Abstract][Full Text] [Related]
4. Prostanoid receptors involved in the relaxation of human pulmonary vessels.
Walch L; Labat C; Gascard JP; de Montpreville V; Brink C; Norel X
Br J Pharmacol; 1999 Feb; 126(4):859-66. PubMed ID: 10193765
[TBL] [Abstract][Full Text] [Related]
5. Relaxant actions of nonprostanoid prostacyclin mimetics on human pulmonary artery.
Jones RL; Qian YM; Wise H; Wong HN; Lam WL; Chan HW; Yim AP; Ho JK
J Cardiovasc Pharmacol; 1997 Apr; 29(4):525-35. PubMed ID: 9156364
[TBL] [Abstract][Full Text] [Related]
6. Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea-pig ileum.
Lawrence RA; Jones RL; Wilson NH
Br J Pharmacol; 1992 Feb; 105(2):271-8. PubMed ID: 1559125
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein.
Lawrence RA; Jones RL
Br J Pharmacol; 1992 Apr; 105(4):817-24. PubMed ID: 1324050
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of PGI2 mimetics used clinically on the vasorelaxation of human pulmonary arteries and veins, role of the DP-receptor.
Benyahia C; Boukais K; Gomez I; Silverstein A; Clapp L; Fabre A; Danel C; Leséche G; Longrois D; Norel X
Prostaglandins Other Lipid Mediat; 2013 Dec; 107():48-55. PubMed ID: 23850788
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a prostanoid EP3-receptor in guinea-pig aorta: partial agonist action of the non-prostanoid ONO-AP-324.
Jones RL; Qian YM; Chan KM; Yim AP
Br J Pharmacol; 1998 Nov; 125(6):1288-96. PubMed ID: 9863659
[TBL] [Abstract][Full Text] [Related]
11. Modulation of noradrenaline release from the sympathetic nerves of the human saphenous vein and pulmonary artery by presynaptic EP3- and DP-receptors.
Molderings GJ; Colling E; Likungu J; Jakschik J; Göthert M
Br J Pharmacol; 1994 Mar; 111(3):733-8. PubMed ID: 8019753
[TBL] [Abstract][Full Text] [Related]
12. A novel inhibitory prostanoid receptor in piglet saphenous vein.
Coleman RA; Grix SP; Head SA; Louttit JB; Mallett A; Sheldrick RL
Prostaglandins; 1994 Feb; 47(2):151-68. PubMed ID: 8016385
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues.
Matthews JS; Jones RL
Br J Pharmacol; 1993 Feb; 108(2):363-9. PubMed ID: 8448586
[TBL] [Abstract][Full Text] [Related]
14. Prostacyclin release and receptor activation: differential control of human pulmonary venous and arterial tone.
Norel X; Walch L; Gascard JP; deMontpreville V; Brink C
Br J Pharmacol; 2004 Jun; 142(4):788-96. PubMed ID: 15172959
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the prostanoid receptors mediating constriction and relaxation of human isolated uterine artery.
Baxter GS; Clayton JK; Coleman RA; Marshall K; Sangha R; Senior J
Br J Pharmacol; 1995 Sep; 116(1):1692-6. PubMed ID: 8564239
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues.
Dong YJ; Jones RL; Wilson NH
Br J Pharmacol; 1986 Jan; 87(1):97-107. PubMed ID: 2420404
[TBL] [Abstract][Full Text] [Related]
17. Involvement of TP and EP3 receptors in vasoconstrictor responses to isoprostanes in pulmonary vasculature.
Janssen LJ; Tazzeo T
J Pharmacol Exp Ther; 2002 Jun; 301(3):1060-6. PubMed ID: 12023538
[TBL] [Abstract][Full Text] [Related]
18. Differential actions of the prostacyclin analogues treprostinil and iloprost and the selexipag metabolite, MRE-269 (ACT-333679) in rat small pulmonary arteries and veins.
Orie NN; Ledwozyw A; Williams DJ; Whittle BJ; Clapp LH
Prostaglandins Other Lipid Mediat; 2013 Oct; 106():1-7. PubMed ID: 23872196
[TBL] [Abstract][Full Text] [Related]
19. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of noradrenaline release in the rat vena cava via prostanoid receptors of the EP3-subtype.
Molderings G; Malinowska B; Schlicker E
Br J Pharmacol; 1992 Oct; 107(2):352-5. PubMed ID: 1330175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
